Centricity Vision Inc., a global ophthalmic technology company and developer of the ZEPTO IOL Positioning System, announced the launch of ZEPTO Plus™, a new,...
Vanda Pharmaceuticals Inc. and OliPass Corporation (OliPass) announced that they have entered into a research and development collaboration agreement to jointly develop a set...
The U.S. Food and Drug Administration approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's...
Synaptogenix, Inc., an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, commented on the positive Phase 3 trial results for Lecanemab announced last...
Cell coding company bit.bio has announced an expansion to its product portfolio - ioGlutamatergic Neurons TDP-43M337V disease model and early access to its ioMicroglia...
